United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2325_3c16209f-1ef5-4738-b6c1-eb3afac50967
- Product NDC
- 71335-2325
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020703
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 112 TABLET in 1 BOTTLE (71335-2325-0) · 71335-2325-0
- 30 TABLET in 1 BOTTLE (71335-2325-1) · 71335-2325-1
- 60 TABLET in 1 BOTTLE (71335-2325-2) · 71335-2325-2
- 90 TABLET in 1 BOTTLE (71335-2325-3) · 71335-2325-3
- 120 TABLET in 1 BOTTLE (71335-2325-4) · 71335-2325-4
- 20 TABLET in 1 BOTTLE (71335-2325-5) · 71335-2325-5
- 45 TABLET in 1 BOTTLE (71335-2325-6) · 71335-2325-6
- 140 TABLET in 1 BOTTLE (71335-2325-7) · 71335-2325-7
- 84 TABLET in 1 BOTTLE (71335-2325-8) · 71335-2325-8
- 28 TABLET in 1 BOTTLE (71335-2325-9) · 71335-2325-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →